Topical NSAID – Combines 2% diclofenac sodium with the transdermal drug carrier dimethyl sulfoxide (DMSO).

  • Indication: Treating the pain of osteoarthritis of the knee.
  • Formulation:
    • Low systemic exposure to minimize side effects.
    • Metered dose dispenser.
  • Intellectual Property
    • Patents issued in nineteen countries (ex-U.S.) and pending in five countries with the latest expiring 2027.

  Awaiting DCGI approval

For more information on PENNSAID®
Please refer https://www.pennsaid.com/ or contact your local sales representative or email us at info@sayretherapeutics.com

pennsaid - osteoarthritis applier